CRNO B
3.55 SEK
-0.04 (-1.06%)

Cereno Scientific will participate at the 22nd Global CVCT Forum on December 8-10 in Washington D.C., US. CVCT is a recognized and respected organization that aims to bring clinicians, patients, researchers, regulators, funders, payers, and other stakeholders together to promote the most effective cutting-edge progress in medical evidence generation and implementation.

Find more information: https://www.globalcvctforum.com/